Roivant Sciences Ltd. (ROIV)
29.06
+0.56
(+1.98%)
USD |
NASDAQ |
Jun 09, 16:00
29.06
0.00 (0.00%)
After-Hours: 20:00
Roivant Sciences Total Liabilities (Quarterly) : 435.63M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Centessa Pharmaceuticals Plc | 154.42M |
| Aptorum Group Ltd. | 4.900M |
| Bicycle Therapeutics Plc | 98.08M |
| Adaptimmune Therapeutics Plc | 201.59M |
| Kiniksa Pharmaceuticals International Plc | 219.59M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.728B |
| Shareholders Equity (Quarterly) | 4.527B |
| Debt to Equity Ratio | 0.0237 |
| Current Ratio | 18.37 |
| Net Debt Paydown Yield | -0.01% |